Overexpression of estrogen receptor beta and its prognostic significance among malignant pleural mesothelioma patients

被引:0
|
作者
Helali, Mariam [1 ,3 ]
Abdelmotal, Ahmed [1 ]
Gobran, Nagy [1 ]
El Ghazaly, Hesham [1 ]
El Mahdy, Manal [2 ]
Karim, Khaled [1 ]
机构
[1] Ain Shams Univ, Fac Med, Clin Oncol Dept, Cairo, Egypt
[2] Ain Shams Univ, Fac Med, Pathol Dept, Cairo, Egypt
[3] 38 Abbassia,Next Al Nour Mosque, Cairo, Egypt
关键词
mesothelioma; ER beta; prognostic; biomarkers; HEALTH;
D O I
10.4103/ecdt.ecdt_25_23
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background The overexpression of estrogen receptor beta (ER beta) and its correlation with prognosis of malignant mesothelioma remains controversial and unexplored. This study aimed at studying ER beta expression in tumour tissue in patients with pleural mesothelioma and its association with clinical and pathological factors and survival analysis. Material and methods A prospective cohort study was conducted on patients who were diagnosed with malignant pleural mesothelioma (MPM) in Ain Shams university hospitals, the primary end point was to correlate ER beta overexpression that was analysed by immunohistochemistry (IHC) on paraffin tissue blocks with 1-year overall survival (OS) among MPM patients, the secondary endpoint was to correlate ER beta overexpression with 1-year progression free survival (PFS) and response to platinum-based chemotherapy among MPM patients. Results A total 42 MPM patients were included, High ER beta expression (modified Allred score 7-9) was reported in 9.5% of the patients (4 cases), moderate expression (modified Allred score 4-6) was reported in 28.6% of the patients(12 cases), weak and negative expression ( modified Allred score 0-3) was reported in 61% of the patients(26 cases), percent of ER beta positive cases was 69% of the total patients, there was no statistical difference as regard age (p value:0.8), sex(p value:0.4), stage (p value: 0.71), ECOG (p value :0.84) , histological subtype(p value:0.17) and response to platinum based treatment (p value:0.5) across the 3 groups of patients (high, moderate , weak and negative ER beta on tumour tissues) there was no statistically significant difference in OS and PFS for ER beta overexpression. Conclusion The overexpression of ER beta was not associated with improved OS or PFS in mesothelioma patients, despite high rate of ER beta positive cases in our analysis, larger sample size would be recommended for more solid conclusions
引用
收藏
页码:85 / 90
页数:6
相关论文
共 50 条
  • [21] Prognostic factors for malignant pleural mesothelioma
    Fraser J. H. Brims
    Nick A. Maskell
    Current Respiratory Care Reports, 2013, 2 (2): : 100 - 108
  • [22] Prognostic factors for malignant pleural mesothelioma
    Brims, Fraser J. H.
    Maskell, Nick A.
    CURRENT PULMONOLOGY REPORTS, 2013, 2 (02) : 100 - 108
  • [23] Prognostic factors in malignant pleural mesothelioma
    Davidson, Ben
    HUMAN PATHOLOGY, 2015, 46 (06) : 789 - 804
  • [24] Prognostic characteristics of malignant pleural mesothelioma
    Metintas, Muzaffer
    Ak, Guntulu
    Metintas, Selma
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [25] Prognostic Factors in Malignant Pleural Mesothelioma
    Kirschner, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S12 - S12
  • [26] PROGNOSTIC BIOMARKERS IN MALIGNANT PLEURAL MESOTHELIOMA
    Mezzapelle, R.
    Miglio, U.
    Rena, O.
    Mercalli, F.
    Veggiani, C.
    Paganotti, A.
    Buosi, R.
    Rinaldi, M.
    Boldorini, R.
    ANNALS OF ONCOLOGY, 2014, 25
  • [27] Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma
    Thylén, A
    Hjerpe, A
    Martensson, G
    CANCER, 2001, 92 (05) : 1224 - 1230
  • [28] Steroid receptor coactivators in malignant pleural mesothelioma: expression and prognostic value
    Jennings, C. J.
    O'Grady, A.
    Cummins, R.
    Murer, B.
    Kay, E. W.
    Harvey, B. J.
    Thomas, W.
    LUNG CANCER, 2012, 75 : S21 - S22
  • [29] Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma
    Liu, Hui
    Wu, Licun
    Ji, Kai
    Wang, Wei
    TUMOR BIOLOGY, 2015, 36 (10) : 7375 - 7384
  • [30] PROGNOSTIC EVALUATION OF PATIENTS SUBMITTED TO SURGERY FOR MALIGNANT PLEURAL MESOTHELIOMA
    COLLEONI, M
    BONI, L
    CALABRO, F
    MANENTE, P
    NELLI, P
    GAION, F
    PANCHERI, F
    SARTORI, F
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 6 (06) : 1261 - 1265